|
dt881
|
6436173
|
Rifaximin
|
93777907
|
rpoB
|
Escherichia coli K-12
|
--
|
Inhibitor
|
Details
|
|
dt882
|
6436173
|
Rifaximin
|
8856
|
NR1I2
|
Homo sapiens (human)
|
--
|
Agonist
|
Details
|
|
dt883
|
6436173
|
Rifaximin
|
1576
|
CYP3A4
|
Homo sapiens (human)
|
--
|
Substrate|Inducer
|
Details
|
|
dt884
|
6436173
|
Rifaximin
|
1557
|
CYP2C19
|
Homo sapiens (human)
|
--
|
Inducer
|
Details
|
|
dt885
|
6436173
|
Rifaximin
|
1558
|
CYP2C8
|
Homo sapiens (human)
|
11996015
|
Inducer
|
Details
|
|
dt886
|
6436173
|
Rifaximin
|
8856
|
NR1I2
|
Homo sapiens (human)
|
22790967
|
[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CD36 protein|[nr1i2 results in increased susceptibility to rifaximin] which results in increased expression of CFD mrna|[nr1i2 results in increased susceptib
|
Details
|
|
dt887
|
6436173
|
Rifaximin
|
8856
|
NR1I2
|
Homo sapiens (human)
|
21599020
|
[rifaximin binds to and results in increased activity of NR1I2 protein] inhibits the reaction [trinitrobenzenesulfonic acid results in increased expression of TNF protein]|[rifaximin binds to and results in increased activity of NR1I2 protein] inhibits th
|
Details
|
|
dt888
|
6436173
|
Rifaximin
|
8856
|
NR1I2
|
Homo sapiens (human)
|
--
|
Rifaximin results in increased activity of NR1I2 protein
|
Details
|
|
dt889
|
6436173
|
Rifaximin
|
8856
|
NR1I2
|
Homo sapiens (human)
|
--
|
Rifaximin results in increased expression of NR1I2 mRNA
|
Details
|
|
dt890
|
6445781
|
Cp-461
|
246
|
ALOX15
|
Homo sapiens (human)
|
16166323
|
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of ALOX15 protein|(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression
|
Details
|